45 results
DEFA14A
REGN
Regeneron Pharmaceuticals, Inc.
17 May 23
Additional proxy soliciting materials
4:04pm
diverse (African American – 1, Asian – 2, Middle Eastern/Arab American – 1). As disclosed in the 2023 Proxy Statement, following the 2023 Annual
DEFA14A
2k1l5nd
21 Apr 22
Additional proxy soliciting materials
4:21pm
CORRESP
omnxnnzo70
7 Dec 20
Correspondence with SEC
12:00am